Dept of Pharma implementing PLI Scheme for Pharma at cost of Rs 15,000 cr

New Delhi: The Department of Pharmaceuticals is implementing the Production Linked Incentive (PLI) Scheme for Pharmaceuticals with a total financial outlay of Rs. 15,000 crore and scheme tenure up to FY 2027-28, Ministry of Chemicals and Fertilizers informed Lok Sabha on Friday.

Sun Pharma Q4FY24 PAT grows 34% to Rs 2,655 cr; Rs 5 per share dividend declared

Mumbai: Leading pharmaceutical company Sun Pharmaceutical Industries Ltd announced a consolidated net profit of Rs 2,654.5 crore for the March quarter, a 34 percent increase from the same period last year, media reported.

Cipla Q4FY24: Net profit grows 79% YoY to Rs 939 cr

Mumbai: Pharma giant Cipla’s consolidated net profit grew 79% rising to Rs 939.04 crore in Q4 FY24 over Q4 FY23.

Strides Pharma Q4FY23 sales at Rs 9,904 million cr, up 14%Y-o-Y; loss narrows 133% YoY to Rs 9.54 cr

Mumbai: Strides Pharma’s quarterly sales stood at Rs 9,904 million, growing 14% increase both sequentially and year-on-year.

India’s pharma exports grow by 103 pc since 2013-14

New Delhi: Indian pharma exports witnessed a growth of 103 percent since 2013-14, from Rs 90,415 crores to Rs 1,83,422 crores in 2021-22. 

India poised to become 'global hub for medicines': DCGI

New Delhi: There has been a fourfold increase in applications of the investigational new drugs in the country, according to Dr VG Somani, Drug Controller General of India (DCGI), media reports said.

Strides Pharma records 11 pc YoY revenue increase in Q2FY21

Kolkata/IBNS: Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) today announced its consolidated financial results for the quarter (Q2FY21).